AnMed Health

The trials here

What the 19 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease7 trials
• High blood pressure4 trials
• Pulmonary arterial hypertension3 trials
• Atrial fibrillation2 trials
• COPD2 trials
• Brain metastases1 trial
• Bronchiectasis1 trial
• Childhood cancers1 trial
• Deep vein thrombosis and pulmonary embolism1 trial
• Heart failure1 trial
• Melanoma1 trial
• Peripheral artery disease1 trial
• and 1 more

Phase

• Phase 36 trials
• Phase 21 trial

Status

• Active, not recruiting9 trials
• Recruiting5 trials
• Completed4 trials
• Terminated1 trial

Lead sponsor

• Abbott Medical Devices2 trials
• Janssen Research & Development, LLC2 trials
• Actelion1 trial
• Biosensors Europe SA1 trial
• Biotronik, Inc.1 trial
• and 12 more

Running trials

• Recruiting

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

  NCT07430956· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  NCT06388421· United Therapeutics· Source

  Contact: Abhijit Raval, MD

• Active, not recruiting

  A Study to Evaluate Solrikitug in Participants With COPD (ZION)

  NCT06496620· Phase 2· Uniquity One (UNI)· Source

• Recruiting

  Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

  NCT05677100· Procyrion· Source

  Contact: Jennifer Lee

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  XIENCE Skypoint Large Vessel Post Approval Study

  NCT05423379· Abbott Medical Devices· Source

• Recruiting

  STRIVE Post-Market Registry Study

  NCT04302272· Olympus Corporation of the Americas· Source

  Contact: Melissa Frankum

• Active, not recruiting

  Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

  NCT04674683· Phase 3· HUYABIO International, LLC.· Source

• Active, not recruiting

  Firehawk Rapamycin Target Eluting Coronary Stent North American Trial

  NCT04562532· Shanghai MicroPort Medical (Group) Co., Ltd.· Source

• Active, not recruiting

  LIFE-BTK Randomized Controlled Trial

  NCT04227899· Abbott Medical Devices· Source

• Active, not recruiting

  Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

  NCT04273945· Phase 3· Actelion· Source

• Active, not recruiting

  LEADERS FREE II: BioFreedom™ Pivotal Study

  NCT02843633· Biosensors Europe SA· Source

• Recruiting

  Pulmonary Hypertension Association Registry

  NCT04071327· Pulmonary Hypertension Association, Inc.· Source

  Contact: Abhijit Raval, MD

• Active, not recruiting

  PRE-DETERMINE Cohort Study

  NCT01114269· Brigham and Women's Hospital· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure2 recruiting
• Pulmonary arterial hypertension2 recruiting
• Atrial fibrillation1 recruiting
• COPD1 recruiting
• Deep vein thrombosis and pulmonary embolism1 recruiting
• Heart failure1 recruiting
• Stroke1 recruiting

Closed trials

• Terminated

  ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

  NCT06418711· Phase 3· Mannkind Corporation· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

  NCT04175626· Biotronik, Inc.· Source

• Completed

  PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

  NCT03168776· Sino Medical Sciences Technology Inc.· Source

• Completed

  SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System

  NCT02439775· Medtronic Vascular· Source